title: Systematic review suggests TNF-α inhibitors may be rational options for pregnant patients with inflammatory bowel disease.
authors.affiliation: Division of Gastroenterology, University of California San Diego, , La Jolla, California, USA;
authors.forename: Barrett G
authors.initials: BG
authors.lastname: Levesque
authors.forename: Marlene E
authors.initials: ME
authors.lastname: Pountney-Levesque
mesh_terms: D000818:Animals; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D011297:Prenatal Exposure Delayed Effects / Q000175:diagnosis*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D014409:Tumor Necrosis Factor-alpha